/NVR%20Inc_%20phone%20and%20website%20by-%20T_Schneider%20via%20Shutterstock.jpg)
Over the past year, NVR has delivered performance that surpasses the broader market. However, Wall Street analysts are cautious about its growth outlook.
/Biogen%20Inc%20logo%20on%20HQ-by%20Tada%20Images%20via%20Shutterstock.jpg)
Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Lennar%20Corp_%20phone%20and%20webpage%20by-%20Wirestock%20Creators%20via%20Shutterstock.jpg)
Lennar has significantly outperformed the broader market over the past year, yet analysts are moderately bullish on the stock's outlook.
/Biogen%20Inc%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Despite Biogen’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.